The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read moreNote: This article was first published in The Pharmaceutical Journal. By Dr. James Davies, Director of Research and Insights at Community Pharmacy England Every day across England, community pharmacy teams are doing extraordinary work under extraordinary pressures. Across the sector, we’re seeing growing workloads, overwhelming medicine supply and pricing issues, and the increasing challenge of
Read moreMHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) Drug alert number: EL(26)A/17 Date issued: 26 March 2026 Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information. DMRC reference number: DMRC-38614094 Marketing Authorisation Holder: Sandoz Limited Medicine Details Product
Read more
NHS England has issued an operational briefing via its regions to all pharmacies and general practices providing an update on the Meningococcal disease outbreak in Kent and announcing the waiving of NHS prescription charges for prophylactic oral Ciprofloxacin prescriptions issued to patients in relation to the outbreak. Prescribers in general practices have been asked to
Read moreMHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited) Drug alert number: EL(26)A/16 Date issued: 26 March 2026 Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton. DMRC
Read moreRegular occurrences of abuse against community pharmacy teams are making their working life increasingly difficult, and at times dangerous, new research from Community Pharmacy England has demonstrated. A recent survey of more than 3,000 pharmacy premises found that: More than half (55%) of pharmacies had experienced verbal abuse in the preceding six months, with three-quarters
Read moreAs part of Community Pharmacy England’s commitment to working more closely with pharmacy owners – listening to them better, as well as engaging more regularly via events and other channels – we sought input from the sector ahead of the February 2026 Committee Meeting. Between 12th December 2025 and 22nd January 2026, the latest sector
Read moreThe Department of Health and Social Care (DHSC) has today (24/03/2026) confirmed the following list of price concessions for March 2026: Drug Pack size Price concession Adapalene 0.1% cream 45 £18.26 Adapalene 0.1% gel 45 £18.26 Alfuzosin 2.5mg tablets 60 £6.67 Amlodipine 2.5mg tablets 28 £3.88 Aripiprazole 15mg tablets 28 £1.02 Aspirin 75mg dispersible tablets 28
Read moreThe Royal Pharmaceutical Society (RPS) – supported by Community Pharmacy England, charities and patient groups – is calling on the Government to make headway in introducing community pharmacist flexibilities and addressing reimbursement issues that can delay access to medicines. Medicines Shortages: One Year On assesses progress on supply issues since the launch of the RPS’s
Read moreMHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) Drug alert number: EL(26)A/15 Date issued: 23 March 2026 Mölnlycke Health Care are recalling specific batches of Hibiwash® due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. DMRC reference number: DMRC-38814497 Company name:Regent Medical Limited / Mölnlycke Health
Read more
